Company / PP&E per Share
IOVANCE BIOTHERAPEUTICS, INC. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.43
FY2025
5-year range
$0.43 / $660.76
FY2021-FY2025
Trend
+0.9%
vs FY2024
Sector context
#57 of 191
Health Care
What the data says
At $0.43, IOVANCE BIOTHERAPEUTICS, INC.'s pp&e per share ranks #57 of 191 in the Health Care sector. PP&E per Share returned to growth in FY2025 after 2 years of decline, reaching $0.43.
Based on SEC 10-K filings.
0.43 in FY2025 with a 5-year CAGR of -74.9%.
Declined from $0.61 to $0.43 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -91.3%
- 5-Year CAGR
- -74.9%
- 10-Year CAGR
- -
Sector benchmark
#57 of 191 in Health CareTop 30% of 191This company $0.43 Sector average $18.90
▼
-97.7% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 0.9% year-over-year.
- Ranks #57 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2022.
- Lowest pp&e per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.43 | +0.9% |
| FY2024 | $0.43 | -29.9% |
| FY2023 | $0.61 | -99.9% |
| FY2022 | $660.76 | +0.4% |
| FY2021 | $657.98 | +53.8% |
| FY2020 | $427.76 | +523.1% |
| FY2019 | $68.65 | +187114.6% |
| FY2018 | $0.04 | -6.8% |
| FY2017 | $0.04 | -19.5% |
| FY2016 | $0.05 | -1.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026